International Journal of STD & AIDS > Volume 20, Number 10 > Pp. 671-674

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Wylie, K Articles by Malik, F PubMed PubMed Citation Social Bookmarking                      What's this?

Review

Review of drug treatment for female sexual dysfunction

K Wylie FRCP FRCPsych  and F Malik

Porterbrook Clinic, Sheffield, UK

Correspondence to: Dr K Wylie Email: k.r.wylie{at}sheffield.ac.uk

Female sexual dysfunction (FSD) incorporates various sexual disorders including hypoactive sexual desire disorder, sexual arousal disorder, orgasmic and sexual pain disorders. Although many strategies have been formulated for the treatment of male sexual problems, FSD remains an area that warrants further research and trial studies to identify the most efficacious treatment options. Research has highlighted numerous pharmacological interventions that have been trialled and found to exhibit positive effects. These include hormonal therapies, prostaglandins, dopaminergic agonists, phosphodiesterase type-5 (PDE-5) inhibitors and melanocortin agonists.

Key Words: women • desire • arousal • orgasm • pain • pharmacology

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?